Search research articles
Contact Us
Filters
Showing results (201-210 of 214) with videos related to
Page
of 22
Sort By:
The Journal of Molecular Diagnostics : JMD
|
February 11, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients
C H Takimoto, G Morrison, N Harold, et al.
American Journal of Clinical Pathology
|
February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of the National Cancer Institute
|
August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Anna D Wagner, Axel Grothey, Thierry Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2019
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
Kathryn L Penney, Barbara L Banbury, Stephanie Bien, et al.
Journal of the National Cancer Institute
|
September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Breast Cancer Research : BCR
|
December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Breast Cancer Research : BCR
|
January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04
Michael J O'Connell, Linda H Colangelo, Robert W Beart, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 214) with videos related to
Sort By:
Page
of 22
The Journal of Molecular Diagnostics : JMD
|
February 11, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2000
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients
C H Takimoto, G Morrison, N Harold, et al.
American Journal of Clinical Pathology
|
February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Journal of the National Cancer Institute
|
August 25, 2020
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database
Anna D Wagner, Axel Grothey, Thierry Andre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 7, 2017
Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and the American Society of Clinical Oncology
Antonia R Sepulveda, Stanley R Hamilton, Carmen J Allegra, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2019
Genetic Variant Associated With Survival of Patients With Stage II-III Colon Cancer
Kathryn L Penney, Barbara L Banbury, Stephanie Bien, et al.
Journal of the National Cancer Institute
|
September 17, 2015
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J Allegra, Greg Yothers, Michael J O'Connell, et al.
Breast Cancer Research : BCR
|
December 5, 2019
NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2<sup>+</sup> breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Breast Cancer Research : BCR
|
January 24, 2020
Correction to: NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
Samuel A Jacobs, André Robidoux, Jame Abraham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 7, 2014
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04
Michael J O'Connell, Linda H Colangelo, Robert W Beart, et al.
Page
of 22